Walleye Capital
THC icon

Walleye Capital’s Tenet Healthcare THC Stock Holding History

Walleye Capital’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$786K Buy
4,200
+2,000
+91% +$368K ﹤0.01% 2330
2026
Q1 		$415K Sell
2,200
-8,200
-79% -$1.73M ﹤0.01% 2804
2025
Q4 		$2.07M Buy
+10,400
New +$2.1M 0.01% 1849
2025
Q3 		– Sell
-11,800
Closed -$2.08M – 5122
2025
Q2 		$2.08M Buy
11,800
+5,100
+76% +$768K 0.01% 1484
2025
Q1 		$901K Sell
6,700
-1,300
-16% -$171K ﹤0.01% 2054
2024
Q4 		$1.01M Sell
8,000
-13,700
-63% -$2.04M ﹤0.01% 2382
2024
Q3 		$3.61M Sell
21,700
-23,700
-52% -$3.58M 0.01% 1421
2024
Q2 		$6.04M Sell
45,400
-16,400
-27% -$1.97M 0.01% 1155
2024
Q1 		$6.5M Buy
61,800
+52,900
+594% +$4.75M 0.01% 1113
2023
Q4 		$673K Sell
8,900
-34,800
-80% -$2.21M ﹤0.01% 2707
2023
Q3 		$2.88M Buy
+43,700
New +$3.27M 0.01% 1443
2023
Q2 		– Sell
-4,300
Closed -$256K – 4876
2023
Q1 		$256K Buy
4,300
+4,100
+2,050% +$228K ﹤0.01% 2254
2022
Q4 		$9.76K Buy
+200
New +$9.24K ﹤0.01% 2763
2020
Q1 		– Sell
-25,700
Closed -$977K – 1647
2019
Q4 		$977K Sell
25,700
-3,600
-12% -$108K 0.06% 427
2019
Q3 		$648K Buy
29,300
+14,200
+94% +$303K 0.04% 628
2019
Q2 		$312K Buy
+15,100
New +$348K 0.03% 716

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Walleye Capital's THC Position: Q2 2026 in Review

Walleye Capital increased its Tenet Healthcare (THC) stake by 693% in Q2 2026, buying an estimated $111K and bringing the position to 690 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #3745.

Walleye Capital first reported a position in THC in Q4 2019 and has held it in 24 quarters since. The position peaked at $31.6M in Q2 2025. 680 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Walleye Capital held 690 shares of Tenet Healthcare worth $129K as of Q2 2026.
  • Walleye Capital bought 603 Tenet Healthcare shares in Q2 2026, an estimated $111K.
  • Tenet Healthcare made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3745 holding.
  • Walleye Capital first reported a position in Tenet Healthcare in Q4 2019 and has held it in 24 quarters since.
  • Walleye Capital's Tenet Healthcare position peaked at $31.6M in Q2 2025.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.